BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27456844)

  • 1. A comparison of two methods for expert elicitation in health technology assessments.
    Grigore B; Peters J; Hyde C; Stein K
    BMC Med Res Methodol; 2016 Jul; 16():85. PubMed ID: 27456844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EXPLICIT: a feasibility study of remote expert elicitation in health technology assessment.
    Grigore B; Peters J; Hyde C; Stein K
    BMC Med Inform Decis Mak; 2017 Sep; 17(1):131. PubMed ID: 28870196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study.
    Bojke L; Soares M; Claxton K; Colson A; Fox A; Jackson C; Jankovic D; Morton A; Sharples L; Taylor A
    Health Technol Assess; 2021 Jun; 25(37):1-124. PubMed ID: 34105510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informing Reimbursement Decisions Using Cost-Effectiveness Modelling: A Guide to the Process of Generating Elicited Priors to Capture Model Uncertainties.
    Bojke L; Grigore B; Jankovic D; Peters J; Soares M; Stein K
    Pharmacoeconomics; 2017 Sep; 35(9):867-877. PubMed ID: 28616775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.
    Karnon J; Czoski-Murray C; Smith K; Brand C; Chakravarthy U; Davis S; Bansback N; Beverley C; Bird A; Harding S; Chisholm I; Yang YC
    Health Technol Assess; 2008 Jun; 12(27):iii-iv, ix-124. PubMed ID: 18513468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
    Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
    Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting.
    McCullagh L; Walsh C; Barry M
    Pharmacoeconomics; 2012 Oct; 30(10):941-59. PubMed ID: 22667458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment.
    Grigore B; Peters J; Hyde C; Stein K
    Pharmacoeconomics; 2013 Nov; 31(11):991-1003. PubMed ID: 24105473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
    Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K
    Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eliciting distributions to populate decision analytic models.
    Bojke L; Claxton K; Bravo-Vergel Y; Sculpher M; Palmer S; Abrams K
    Value Health; 2010 Aug; 13(5):557-64. PubMed ID: 20345548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
    Sharma P; Boyers D; Boachie C; Stewart F; Miedzybrodzka Z; Simpson W; Kilonzo M; McNamee P; Mowatt G
    Health Technol Assess; 2012; 16(17):1-266. PubMed ID: 22469073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect.
    Jankovic D; Payne K; Kanaan M; Bojke L
    Int J Technol Assess Health Care; 2022 Feb; 38(1):e21. PubMed ID: 35177145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference Case Methods for Expert Elicitation in Health Care Decision Making.
    Bojke L; Soares MO; Claxton K; Colson A; Fox A; Jackson C; Jankovic D; Morton A; Sharples LD; Taylor A
    Med Decis Making; 2022 Feb; 42(2):182-193. PubMed ID: 34271832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a practical approach to expert elicitation for randomised controlled trials with missing health outcomes: Application to the IMPROVE trial.
    Mason AJ; Gomes M; Grieve R; Ulug P; Powell JT; Carpenter J
    Clin Trials; 2017 Aug; 14(4):357-367. PubMed ID: 28675302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.
    Claxton K; Martin S; Soares M; Rice N; Spackman E; Hinde S; Devlin N; Smith PC; Sculpher M
    Health Technol Assess; 2015 Feb; 19(14):1-503, v-vi. PubMed ID: 25692211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project.
    Lord J; Willis S; Eatock J; Tappenden P; Trapero-Bertran M; Miners A; Crossan C; Westby M; Anagnostou A; Taylor S; Mavranezouli I; Wonderling D; Alderson P; Ruiz F
    Health Technol Assess; 2013 Dec; 17(58):v-vi, 1-192. PubMed ID: 24325843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expert Elicitation to Inform a Cost-Effectiveness Analysis of Screening for Renal Cancer.
    Rossi SH; Blick C; Nathan P; Nicol D; Stewart GD; Wilson ECF
    Value Health; 2019 Sep; 22(9):981-987. PubMed ID: 31511187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scenario drafting to anticipate future developments in technology assessment.
    Retèl VP; Joore MA; Linn SC; Rutgers EJ; van Harten WH
    BMC Res Notes; 2012 Aug; 5():442. PubMed ID: 22894140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.